Sponsored by Open Therapeutics. Matching funds are being sought. Details coming soon…
Preclinical study of amphiphilic amines (RC16) for cancer treatment
Sponsored by: Open Therapeutics™
Abstract:
This grant will award up to $3,000.00 towards the winning proposal(s).
Proposals that utilize the following Technologies will be considered: A novel class of antitumor amphiphilic amines (RCn)
Voting Period:
From 2018-09-01 22:00 UTC to 2018-10-01 22:00 UTC